Victory Capital Management
TVRD

Victory Capital Management’s Tvardi Therapeutics TVRD Stock Holding History

Victory Capital Management’s Portfolio TVRD Stock Details TVRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-4,473
Closed -$1.73M – 2704
2022
Q4 		$1.73M Buy
4,473
+1,123
+34% +$427K ﹤0.01% 1495
2022
Q3 		$1.13M Sell
3,350
-366
-10% -$133K ﹤0.01% 1672
2022
Q2 		$1.22M Buy
+3,716
New +$1.3M ﹤0.01% 1655
2022
Q1 		– Sell
-442
Closed -$194K – 2828
2021
Q4 		$194K Buy
442
+8
+2% +$4.02K ﹤0.01% 2488
2021
Q3 		$242K Sell
434
-100
-19% -$50.2K ﹤0.01% 2454
2021
Q2 		$274K Sell
534
-722
-57% -$458K ﹤0.01% 2447
2021
Q1 		$982K Buy
1,256
+200
+19% +$137K ﹤0.01% 1926
2020
Q4 		$575K Sell
1,056
-59
-5% -$30.9K ﹤0.01% 2011
2020
Q3 		$511K Sell
1,115
-418
-27% -$243K ﹤0.01% 1946
2020
Q2 		$944K Sell
1,533
-1,534
-50% -$847K ﹤0.01% 1755
2020
Q1 		$1.46M Buy
3,067
+1,397
+84% +$759K ﹤0.01% 1723
2019
Q4 		$969K Buy
1,670
+48
+3% +$33.7K ﹤0.01% 1765
2019
Q3 		$1.07M Buy
1,622
+1,582
+3,955% +$1.32M ﹤0.01% 1683
2019
Q2 		$31K Hold
40
– – ﹤0.01% 1777
2019
Q1 		$28K Hold
40
– – ﹤0.01% 1737
2018
Q4 		$19K Sell
40
-7
-15% -$4.52K ﹤0.01% 1743
2018
Q3 		$41K Buy
+47
New +$33.9K ﹤0.01% 1735

Other funds holding TVRD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
C
Chescapmanager Baltimore, Maryland $1.12B AUM 67.49% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Victory Capital Management's TVRD Position: Q1 2023 in Review

Victory Capital Management sold out of Tvardi Therapeutics (TVRD) in Q1 2023, closing a stake of 4,473 shares — an estimated $1.73M sold.

Victory Capital Management first reported a position in TVRD in Q3 2018 and held it in 17 quarters. The position peaked at $1.73M in Q4 2022. 162 funds tracked by Wall St. Rank hold TVRD as of Q1 2023.

  • Victory Capital Management reported no remaining Tvardi Therapeutics position as of Q1 2023 after selling out during the quarter.
  • Victory Capital Management sold 4,473 Tvardi Therapeutics shares in Q1 2023, an estimated $1.73M.
  • Victory Capital Management first reported a position in Tvardi Therapeutics in Q3 2018 and held it in 17 quarters.
  • Victory Capital Management's Tvardi Therapeutics position peaked at $1.73M in Q4 2022.
  • 162 funds tracked by Wall St. Rank held Tvardi Therapeutics as of Q1 2023.

Based on Victory Capital Management's 13F filing for Q1 2023, filed 2 May 2023.